Tumor Heterogeneity Makes AML a "Moving Target" for Detection of Residual Disease

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)3-14
JournalCytometry Part B. Clinical Cytometry
Volume86
Issue number1
DOIs
Publication statusPublished - 2014

Cite this